Leukosite Report issue

Contributed to NME For profit
Founded: Cambridge MA United States (1993)
Status: Acquired by Millennium Pharmaceuticals (1999) → now Takeda (2008)

Organization Overview

First Clinical Trial
2001
NCT00038883
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Leudosite

Active Ingredients

Drugs in Other Trials (1)

alemtuzumab (campath) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1